Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94


RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1.

Wang X, Belguise K, O'Neill CF, Sánchez-Morgan N, Romagnoli M, Eddy SF, Mineva ND, Yu Z, Min C, Trinkaus-Randall V, Chalbos D, Sonenshein GE.

Mol Cell Biol. 2009 Jul;29(14):3832-44. doi: 10.1128/MCB.00032-09. Epub 2009 May 11.


Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.

Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE.

Nat Cell Biol. 2007 Apr;9(4):470-8. Epub 2007 Mar 18.


Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide.

Yu Z, Sato S, Trackman PC, Kirsch KH, Sonenshein GE.

PLoS One. 2012;7(3):e33287. doi: 10.1371/journal.pone.0033287. Epub 2012 Mar 15.


Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression.

Vogel CF, Li W, Wu D, Miller JK, Sweeney C, Lazennec G, Fujisawa Y, Matsumura F.

Arch Biochem Biophys. 2011 Aug 1;512(1):78-86. doi: 10.1016/ Epub 2011 May 26.


Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5.

Romagnoli M, Belguise K, Yu Z, Wang X, Landesman-Bollag E, Seldin DC, Chalbos D, Barillé-Nion S, Jézéquel P, Seldin ML, Sonenshein GE.

Cancer Res. 2012 Dec 1;72(23):6268-78. doi: 10.1158/0008-5472.CAN-12-2270. Epub 2012 Oct 10.


Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation.

Mineva ND, Wang X, Yang S, Ying H, Xiao ZX, Holick MF, Sonenshein GE.

J Cell Physiol. 2009 Sep;220(3):593-9. doi: 10.1002/jcp.21765.


NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.

Gionet N, Jansson D, Mader S, Pratt MA.

J Cell Biochem. 2009 Jun 1;107(3):448-59. doi: 10.1002/jcb.22141.


Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.

Qiu J, Wang X, Guo X, Zhao C, Wu X, Zhang Y.

Oncol Rep. 2009 Oct;22(4):935-41.


Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.

Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington KR, Tsimelzon A, Wang T, Hilsenbeck SG, Chamness GC, Andò S, Fuqua SA.

J Natl Cancer Inst. 2011 Apr 6;103(7):538-52. doi: 10.1093/jnci/djr058. Epub 2011 Mar 29.


A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.

Gajulapalli VN, Samanthapudi VS, Pulaganti M, Khumukcham SS, Malisetty VL, Guruprasad L, Chitta SK, Manavathi B.

Biochem J. 2016 Apr 15;473(8):1047-61. doi: 10.1042/BCJ20160019. Epub 2016 Feb 26.


The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells.

Jiang Z, Guo J, Shen J, Jin M, Xie S, Wang L.

J Exp Clin Cancer Res. 2012 May 3;31:42. doi: 10.1186/1756-9966-31-42.


CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.

Mineva ND, Rothstein TL, Meyers JA, Lerner A, Sonenshein GE.

J Biol Chem. 2007 Jun 15;282(24):17475-85. Epub 2007 Apr 19.


Nuclear factor κB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated β-interferon production via induction of transcriptional repressor protein YY1.

Siednienko J, Maratha A, Yang S, Mitkiewicz M, Miggin SM, Moynagh PN.

J Biol Chem. 2011 Dec 30;286(52):44750-63. doi: 10.1074/jbc.M111.250894. Epub 2011 Nov 7.


AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.

Bhat-Nakshatri P, Wang G, Appaiah H, Luktuke N, Carroll JS, Geistlinger TR, Brown M, Badve S, Liu Y, Nakshatri H.

Mol Cell Biol. 2008 Dec;28(24):7487-503. doi: 10.1128/MCB.00799-08. Epub 2008 Oct 6.


Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy.

Liu W, Ip MM, Podgorsak MB, Das GM.

Breast Cancer Res Treat. 2009 May;115(1):43-50. doi: 10.1007/s10549-008-0044-z. Epub 2008 May 15.


Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells.

Ferrand N, Stragier E, Redeuilh G, Sabbah M.

Biochem J. 2012 Oct 1;447(1):71-9. doi: 10.1042/BJ20120311.


Supplemental Content

Support Center